Product Images Bupropion Hydrochloride (xl)

NDC 64679-102-01 is an extended-release tablet of bupropion hydrochloride USP, used once daily. It must not be used with ZYBAN or any other medication with bupropion hydrochloride. The medication guide enclosed should be given to each patient. The dosage is one tablet per day or as prescribed. Manufactured by Wockhardt Limited, and Distributed by Wockhardt Usallc., it comes in 30 tablets. Store the tablet at 20°-25°C (68°-77°F), and Zyban is a registered trademark of GlaxoSmithKline.*

This is a medication called buPROPion HCI Extended-Release Tablet. Each tablet contains 150mg of the active ingredient. It is intended to be taken once a day or as directed by a physician. It is important to read the prescribing information for dosage and administration details. The medication should be stored at 20°-25°C (68°-77°F), and the pharmacist should provide the Medication Guide to each patient. It is not recommended to use in combination with ZYBAN or any other medicine that contains bupropion hydrochloride. This medication is distributed in the USA by Wockhardt USALLC.*

Once-daily bupropion HCI extended-release tablets are available in a bottle of 500 Tablets, and each tablet contains 150mg of bupropion hydrochloride USP. These tablets are used under the direction of a physician and must not be used in combination with other medications that contain bupropion hydrochloride or ZYBAN. The pharmacist should provide the medication guide to each patient. The recommended dosage is one tablet daily, and the tablets must be stored at 20°-25°C (68°-77°F). The tablets are made by Wockhardt Limited and distributed by Wockhardt USA LLC.*

This is a medication with the brand name "buPROPion HCI" that comes in extended-release tablets with a strength of 300mg. The tablets are meant to be taken once daily or as prescribed by a physician. The medication guide provided should be given to each patient by a pharmacist. The medication contains bupropion hydrochloride and should not be used in combination with ZYBAN or any other medicines that contain bupropion hydrochloride. The medication is distributed by Wockhardt USA LLC and should be stored at 20°-25°C (68°-77°F).*

NDC 64679-103-02 Once-Daily bupropion HCI Extended-Release Tablets, USP (XL) 300 mg is a medication that should not be used in combination with ZYBAN or any other medicines containing bupropion hydrochloride. Each extended-release tablet contains 300 mg bupropion hydrochloride and should be taken once daily or as directed by the physician. This medication comes in a pack of 90 tablets and should be stored at 20°-25°C (68°-77°F). The pharmacist should dispense the medication guide provided separately to each patient. Wockhardt Limited manufactures it and it is distributed by Wockhardt USALLC in the USA.*

This is a description of the medication Bupropion Hydrochloride, with NDC 64679-103-05. Each extended-release tablet contains 300mg of Bupropion Hydrochloride USP. The tablet is meant to be taken once daily or as directed by a physician, with dosage information provided in the prescribing information. The medication guide is to be provided separately by the pharmacist. The tablet should be stored at 20°-25°C in a controlled room temperature area. The medication should not be used in combination with ZYBAN or any other medications containing Bupropion Hydrochloride. The tablet is manufactured by Wockhardt Limited and distributed by Wockhardt USA LLC.*